John E Anderson, MD
The Frist Clinic
Evidence-based, patient-centered care and self-management support have been shown to improve patient outcomes in the treatment of type 2 diabetes mellitus (T2DM) as a chronic, complex, progressive disease. To achieve these goals, providers should be knowledgeable of antihyperglycemic regimens recommended in current treatment guidelines so they can discuss them in the context of patient preferences and values as part of shared decision-making. Clinicians also need to be prepared to address common, modifiable barriers to successful initiation, continuation, and intensification of antihyperglycemic therapy while minimizing the risk of hypoglycemia and weight gain. Accordingly, this activity will teach clinicians how to apply the wide array of available antihyperglycemic agents to provide individualized management of hyperglycemia. Simulated patient/clinician interactions will model shared decision-making, and virtual case consults will provide rationale for proposed and selected treatment choices.